Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Alzheimer Disease × fasudil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostate CA 1 Ovarian Neoplasms 1 Lymphoma, Follicular 1 Cognitive Dysfunction 1 Alzheimer Disease 1

Interventions

Dexamethasone 4 Electroencephalography 3 XENP 1595 2 Methods 2 selinexor 1 pomalidomide 1 ixazomib 1 fasudil 1 birtamimab 1 UE2343 1 Transurethral Resection of Bladder 1 Telemedicine 1 Tablets 1 Surgical Procedures, Operative 1 Standard of Care 1 Rosiglitazone 1 Propofol 1 Positron-Emission Tomography 1 Neurofeedback 1 Methotrexate 1 Melphalan 1 Mass Screening 1 Magnetic Resonance Imaging 1 Lysine Acetyltransferase 5 1 Hypnosis 1 Hormones 1 Exercise 1 Ethanol 1 Drug Delivery Systems 1 Donepezil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06362707 2024-10-22

FEAD

Helse Stavanger HF

Phase 2 Recruiting

Alzheimer Disease, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡